Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Humberto Calderón-Fajardo

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Movement Disorders Clinical Practice|October 27, 2018
No Difference on Adherence Between Immediate-Release Versus Extended-Release Dopamine Agonists in Uninsured Subjects with Parkinson's DiseaseLisette Bazán-Rodríguez, Amin Cervantes-Arriaga, Rodrigo Llorens-Arenas, et al.
Neuroscience Journal|September 15, 2015
Change in Motor and Nonmotor Symptoms Severity in a "Real-Life" Cohort of Subjects with Parkinson's DiseaseAdib Jorge de Saráchaga, Amin Cervantes-Arriaga, Rodrigo Llorens-Arenas, et al.
Arquivos De Neuro-Psiquiatria|September 3, 2015
Electroconvulsive therapy in Parkinson's diseaseHumberto Calderón-Fajardo, Amin Cervantes-Arriaga, Rodrigo Llorens-Arenas, et al.
Parkinson'S Disease|November 18, 2014
Independent Validation of the SEND-PD and Correlation with the MDS-UPDRS Part IAMayela Rodríguez-Violante, Amin Cervantes-Arriaga, Salvador Velázquez-Osuna, et al.
Journal of Parkinson'S Disease|September 26, 2015
Impact of Neuropsychiatric Symptoms on the Quality of Life of Subjects with Parkinson's DiseaseAlonso Alvarado-Bolaños, Amin Cervantes-Arriaga, Mayela Rodríguez-Violante, et al.
Journal of the Neurological Sciences|August 16, 2015
Convergent validation of EQ-5D-5L in patients with Parkinson's diseaseAlonso Alvarado-Bolaños, Amin Cervantes-Arriaga, Mayela Rodríguez-Violante, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Movement Disorders Clinical Practice|October 27, 2018
No Difference on Adherence Between Immediate-Release Versus Extended-Release Dopamine Agonists in Uninsured Subjects with Parkinson's DiseaseLisette Bazán-Rodríguez, Amin Cervantes-Arriaga, Rodrigo Llorens-Arenas, et al.
Neuroscience Journal|September 15, 2015
Change in Motor and Nonmotor Symptoms Severity in a "Real-Life" Cohort of Subjects with Parkinson's DiseaseAdib Jorge de Saráchaga, Amin Cervantes-Arriaga, Rodrigo Llorens-Arenas, et al.
Arquivos De Neuro-Psiquiatria|September 3, 2015
Electroconvulsive therapy in Parkinson's diseaseHumberto Calderón-Fajardo, Amin Cervantes-Arriaga, Rodrigo Llorens-Arenas, et al.
Parkinson'S Disease|November 18, 2014
Independent Validation of the SEND-PD and Correlation with the MDS-UPDRS Part IAMayela Rodríguez-Violante, Amin Cervantes-Arriaga, Salvador Velázquez-Osuna, et al.
Journal of Parkinson'S Disease|September 26, 2015
Impact of Neuropsychiatric Symptoms on the Quality of Life of Subjects with Parkinson's DiseaseAlonso Alvarado-Bolaños, Amin Cervantes-Arriaga, Mayela Rodríguez-Violante, et al.
Journal of the Neurological Sciences|August 16, 2015
Convergent validation of EQ-5D-5L in patients with Parkinson's diseaseAlonso Alvarado-Bolaños, Amin Cervantes-Arriaga, Mayela Rodríguez-Violante, et al.
Pageof 1